ACL surgery recovery boost? new trial tests One-Dose Anti-Inflammatory drug

NCT ID NCT07332910

Not yet recruiting Symptom relief Sponsor: Chirec Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a single dose of tranexamic acid (TXA), given during ACL reconstruction surgery, can reduce inflammation and improve early recovery. Sixty adults having ACL surgery will be randomly assigned to receive either TXA or a placebo. The main goal is to measure changes in a key inflammatory marker (IL-6) over the first 24 hours after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACL RECONSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemarthrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Chirec Delta

    Brussels, 1160, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Email: •••••@•••••

    Contact